Peiman Habibollahi
Papers
2
Total Citations
36
H-Index
2
About
Dr. Peiman Habibollahi is a rising leader in interventional oncology, whose research centers on the development and evaluation of minimally invasive, image-guided therapies for solid tumors. His major contributions lie at the intersection of interventional radiology and oncology, particularly in advancing irreversible electroporation (IRE) as a non-thermal ablation technique. His highly cited 2023 work, *New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors* (25 citations), provides a critical synthesis of emerging technologies that spare critical structures while effectively treating challenging tumors. Dr. Habibollahi is also driving evidence-based practice through rigorous comparative effectiveness research. His 2022 protocol for a systematic review and network meta-analysis (11 citations) directly addresses a pressing clinical question: how surgical resection, radiotherapy, and percutaneous thermal ablation compare for stage 1 non-small cell lung cancer. This work is vital for guiding treatment decisions in an increasingly complex patient population. By systematically evaluating these modalities, Dr. Habibollahi is helping to define the optimal role for ablation in lung cancer care. His work is shaping the future of precision, patient-centered oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2